This is the Continuous Integration Build of FHIR (will be incorrect/inconsistent at times).
See the Directory of published versions 
Responsible Owner: Public Health Work Group |
Informative | Use Context: Country: World |
Official URL: http://hl7.org/fhir/ValueSet/vaccine-code
|
Version: 6.0.0-ballot3 | |||
| active as of 2025-11-27 | Computable Name: VaccineAdministeredValueSet | |||
| Flags: | OID: 2.16.840.1.113883.3.88.12.80.22 | |||
This value set is used in the following places:
This identifies the vaccine substance administered - CVX codes.
Generated Narrative: ValueSet vaccine-code
Last updated: 2025-11-27T16:48:47.349Z
This value set includes codes based on the following rules:
http://hl7.org/fhir/sid/cvx
version ⏿20250715urn:oid:1.2.36.1.2001.1005.17 version Not Stated (use latest from terminology server)
This expansion generated 27 Nov 2025
ValueSet
Expansion from tx.fhir.org based on codesystem CVX - US Vaccine Codes v20250715 (CodeSystem) 
This value set contains 360 concepts
| System | Code | Display | Display (English) |
http://hl7.org/fhir/sid/cvx |
01 ![]() |
DTP | diphtheria, tetanus toxoids and pertussis vaccine |
http://hl7.org/fhir/sid/cvx |
02 ![]() |
OPV, trivalent | trivalent poliovirus vaccine, live, oral |
http://hl7.org/fhir/sid/cvx |
03 ![]() |
MMR | measles, mumps and rubella virus vaccine |
http://hl7.org/fhir/sid/cvx |
04 ![]() |
M/R | measles and rubella virus vaccine |
http://hl7.org/fhir/sid/cvx |
05 ![]() |
measles | measles virus vaccine |
http://hl7.org/fhir/sid/cvx |
06 ![]() |
rubella | rubella virus vaccine |
http://hl7.org/fhir/sid/cvx |
07 ![]() |
mumps | mumps virus vaccine |
http://hl7.org/fhir/sid/cvx |
08 ![]() |
Hep B, adolescent or pediatric | hepatitis B vaccine, pediatric or pediatric/adolescent dosage |
http://hl7.org/fhir/sid/cvx |
09 ![]() |
Td (adult), 2 Lf tetanus toxoid, preservative free, adsorbed | tetanus and diphtheria toxoids, adsorbed, preservative free, for adult use (2 Lf of tetanus toxoid and 2 Lf of diphtheria toxoid) |
http://hl7.org/fhir/sid/cvx |
10 ![]() |
IPV | poliovirus vaccine, inactivated |
http://hl7.org/fhir/sid/cvx |
11 ![]() |
pertussis | pertussis vaccine |
http://hl7.org/fhir/sid/cvx |
12 ![]() |
diphtheria antitoxin | diphtheria antitoxin |
http://hl7.org/fhir/sid/cvx |
13 ![]() |
TIG | tetanus immune globulin |
http://hl7.org/fhir/sid/cvx |
14 ![]() |
IG, unspecified formulation | immune globulin, unspecified formulation |
http://hl7.org/fhir/sid/cvx |
15 ![]() |
influenza, split (incl. purified surface antigen) | influenza virus vaccine, split virus (incl. purified surface antigen)-retired CODE |
http://hl7.org/fhir/sid/cvx |
16 ![]() |
influenza, whole | influenza virus vaccine, whole virus |
http://hl7.org/fhir/sid/cvx |
17 ![]() |
Hib, unspecified formulation | Haemophilus influenzae type b vaccine, conjugate unspecified formulation |
http://hl7.org/fhir/sid/cvx |
18 ![]() |
rabies, intramuscular injection | rabies vaccine, for intramuscular injection RETIRED CODE |
http://hl7.org/fhir/sid/cvx |
19 ![]() |
BCG | Bacillus Calmette-Guerin vaccine |
http://hl7.org/fhir/sid/cvx |
20 ![]() |
DTaP | diphtheria, tetanus toxoids and acellular pertussis vaccine |
http://hl7.org/fhir/sid/cvx |
21 ![]() |
varicella | varicella virus vaccine |
http://hl7.org/fhir/sid/cvx |
22 ![]() |
DTP-Hib | DTP-Haemophilus influenzae type b conjugate vaccine |
http://hl7.org/fhir/sid/cvx |
23 ![]() |
plague | plague vaccine |
http://hl7.org/fhir/sid/cvx |
24 ![]() |
Anthrax, pre-exposure prophylaxis, post-exposure prophylaxis | Anthrax vaccine, adsorbed, pre-exposure and post-exposure prophylaxis |
http://hl7.org/fhir/sid/cvx |
25 ![]() |
typhoid, oral | typhoid vaccine, live, oral |
http://hl7.org/fhir/sid/cvx |
26 ![]() |
cholera, unspecified formulation | cholera vaccine, unspecified formulation |
http://hl7.org/fhir/sid/cvx |
27 ![]() |
botulinum antitoxin | botulinum antitoxin |
http://hl7.org/fhir/sid/cvx |
28 ![]() |
DT (pediatric) | diphtheria and tetanus toxoids, adsorbed for pediatric use |
http://hl7.org/fhir/sid/cvx |
29 ![]() |
CMVIG | cytomegalovirus immune globulin, intravenous |
http://hl7.org/fhir/sid/cvx |
30 ![]() |
HBIG | hepatitis B immune globulin |
http://hl7.org/fhir/sid/cvx |
31 ![]() |
Hep A, pediatric, unspecified formulation | hepatitis A vaccine, pediatric dosage, unspecified formulation |
http://hl7.org/fhir/sid/cvx |
32 ![]() |
meningococcal MPSV4 | meningococcal polysaccharide vaccine (MPSV4) |
http://hl7.org/fhir/sid/cvx |
33 ![]() |
pneumococcal polysaccharide PPV23 | pneumococcal polysaccharide vaccine, 23 valent |
http://hl7.org/fhir/sid/cvx |
34 ![]() |
RIG | rabies immune globulin |
http://hl7.org/fhir/sid/cvx |
35 ![]() |
tetanus toxoid, adsorbed | tetanus toxoid, adsorbed |
http://hl7.org/fhir/sid/cvx |
36 ![]() |
VZIG | varicella zoster immune globulin |
http://hl7.org/fhir/sid/cvx |
37 ![]() |
yellow fever live | yellow fever vaccine live |
http://hl7.org/fhir/sid/cvx |
38 ![]() |
rubella/mumps | rubella and mumps virus vaccine |
http://hl7.org/fhir/sid/cvx |
39 ![]() |
Japanese encephalitis SC | Japanese Encephalitis Vaccine SC |
http://hl7.org/fhir/sid/cvx |
40 ![]() |
rabies, intradermal injection | rabies vaccine, for intradermal injection |
http://hl7.org/fhir/sid/cvx |
41 ![]() |
typhoid, parenteral | typhoid vaccine, parenteral, other than acetone-killed, dried |
http://hl7.org/fhir/sid/cvx |
42 ![]() |
Hep B, adolescent/high risk infant | hepatitis B vaccine, adolescent/high risk infant dosage |
http://hl7.org/fhir/sid/cvx |
43 ![]() |
Hep B, adult | hepatitis B vaccine, adult dosage |
http://hl7.org/fhir/sid/cvx |
44 ![]() |
Hep B, high-dosage, dialysis or IC | Hepatitis B vaccine (Hep B), high-dosage, dialysis or immunocompromised patient |
http://hl7.org/fhir/sid/cvx |
45 ![]() |
Hep B, unspecified formulation | hepatitis B vaccine, unspecified formulation |
http://hl7.org/fhir/sid/cvx |
46 ![]() |
Hib (PRP-D) | Haemophilus influenzae type b vaccine, PRP-D conjugate |
http://hl7.org/fhir/sid/cvx |
47 ![]() |
Hib (HbOC) | Haemophilus influenzae type b vaccine, HbOC conjugate |
http://hl7.org/fhir/sid/cvx |
48 ![]() |
Hib (PRP-T) | Haemophilus influenzae type b vaccine, PRP-T conjugate |
http://hl7.org/fhir/sid/cvx |
49 ![]() |
Hib (PRP-OMP) | Haemophilus influenzae type b vaccine, PRP-OMP conjugate |
http://hl7.org/fhir/sid/cvx |
50 ![]() |
DTaP-Hib | DTaP-Haemophilus influenzae type b conjugate vaccine |
http://hl7.org/fhir/sid/cvx |
51 ![]() |
Hib-Hep B | Haemophilus influenzae type b conjugate and Hepatitis B vaccine |
http://hl7.org/fhir/sid/cvx |
52 ![]() |
Hep A, adult | hepatitis A vaccine, adult dosage |
http://hl7.org/fhir/sid/cvx |
53 ![]() |
typhoid, parenteral, AKD (U.S. military) | typhoid vaccine, parenteral, acetone-killed, dried (U.S. military) |
http://hl7.org/fhir/sid/cvx |
54 ![]() |
adenovirus, type 4 | adenovirus vaccine, type 4, live, oral |
http://hl7.org/fhir/sid/cvx |
55 ![]() |
adenovirus, type 7 | adenovirus vaccine, type 7, live, oral |
http://hl7.org/fhir/sid/cvx |
56 ![]() |
dengue fever tetravalent | dengue fever vaccine, tetravalent |
http://hl7.org/fhir/sid/cvx |
57 ![]() |
hantavirus | hantavirus vaccine |
http://hl7.org/fhir/sid/cvx |
58 ![]() |
Hep C | hepatitis C vaccine |
http://hl7.org/fhir/sid/cvx |
59 ![]() |
Hep E | hepatitis E vaccine |
http://hl7.org/fhir/sid/cvx |
60 ![]() |
herpes simplex 2 | herpes simplex virus, type 2 vaccine |
http://hl7.org/fhir/sid/cvx |
61 ![]() |
HIV | human immunodeficiency virus vaccine |
http://hl7.org/fhir/sid/cvx |
62 ![]() |
HPV, quadrivalent | human papilloma virus vaccine, quadrivalent |
http://hl7.org/fhir/sid/cvx |
63 ![]() |
Junin virus | Junin virus vaccine |
http://hl7.org/fhir/sid/cvx |
64 ![]() |
leishmaniasis | leishmaniasis vaccine |
http://hl7.org/fhir/sid/cvx |
65 ![]() |
leprosy | leprosy vaccine |
http://hl7.org/fhir/sid/cvx |
66 ![]() |
Lyme disease | Lyme disease vaccine |
http://hl7.org/fhir/sid/cvx |
67 ![]() |
malaria | malaria vaccine |
http://hl7.org/fhir/sid/cvx |
68 ![]() |
melanoma | melanoma vaccine |
http://hl7.org/fhir/sid/cvx |
69 ![]() |
parainfluenza-3 | parainfluenza-3 virus vaccine |
http://hl7.org/fhir/sid/cvx |
70 ![]() |
Q fever | Q fever vaccine |
http://hl7.org/fhir/sid/cvx |
71 ![]() |
RSV-IGIV | respiratory syncytial virus immune globulin, intravenous |
http://hl7.org/fhir/sid/cvx |
72 ![]() |
rheumatic fever | rheumatic fever vaccine |
http://hl7.org/fhir/sid/cvx |
73 ![]() |
Rift Valley fever | Rift Valley fever vaccine |
http://hl7.org/fhir/sid/cvx |
74 ![]() |
rotavirus, tetravalent | rotavirus, live, tetravalent vaccine |
http://hl7.org/fhir/sid/cvx |
75 ![]() |
Vaccinia (smallpox, mpox), live | Vaccinia (smallpox, mpox) vaccine, live |
http://hl7.org/fhir/sid/cvx |
76 ![]() |
Staphylococcus bacterio lysate | Staphylococcus bacteriophage lysate |
http://hl7.org/fhir/sid/cvx |
77 ![]() |
Tick-borne encephalitis vaccine (non-US) | Tick-borne encephalitis vaccine (non-US) |
http://hl7.org/fhir/sid/cvx |
78 ![]() |
tularemia vaccine | tularemia vaccine |
http://hl7.org/fhir/sid/cvx |
79 ![]() |
vaccinia immune globulin | vaccinia immune globulin |
http://hl7.org/fhir/sid/cvx |
80 ![]() |
VEE, live | Venezuelan equine encephalitis, live, attenuated |
http://hl7.org/fhir/sid/cvx |
81 ![]() |
VEE, inactivated | Venezuelan equine encephalitis, inactivated |
http://hl7.org/fhir/sid/cvx |
82 ![]() |
adenovirus, unspecified formulation | adenovirus vaccine, unspecified formulation |
http://hl7.org/fhir/sid/cvx |
83 ![]() |
Hep A, ped/adol, 2 dose | hepatitis A vaccine, pediatric/adolescent dosage, 2 dose schedule |
http://hl7.org/fhir/sid/cvx |
84 ![]() |
Hep A, ped/adol, 3 dose | hepatitis A vaccine, pediatric/adolescent dosage, 3 dose schedule |
http://hl7.org/fhir/sid/cvx |
85 ![]() |
Hep A, unspecified formulation | hepatitis A vaccine, unspecified formulation |
http://hl7.org/fhir/sid/cvx |
86 ![]() |
IG | immune globulin, intramuscular |
http://hl7.org/fhir/sid/cvx |
87 ![]() |
IGIV | immune globulin, intravenous |
http://hl7.org/fhir/sid/cvx |
88 ![]() |
influenza, unspecified formulation | influenza virus vaccine, unspecified formulation |
http://hl7.org/fhir/sid/cvx |
89 ![]() |
polio, unspecified formulation | poliovirus vaccine, unspecified formulation |
http://hl7.org/fhir/sid/cvx |
90 ![]() |
rabies, unspecified formulation | rabies vaccine, unspecified formulation |
http://hl7.org/fhir/sid/cvx |
91 ![]() |
typhoid, unspecified formulation | typhoid vaccine, unspecified formulation |
http://hl7.org/fhir/sid/cvx |
92 ![]() |
VEE, unspecified formulation | Venezuelan equine encephalitis vaccine, unspecified formulation |
http://hl7.org/fhir/sid/cvx |
93 ![]() |
RSV-MAb | respiratory syncytial virus monoclonal antibody (palivizumab), intramuscular |
http://hl7.org/fhir/sid/cvx |
94 ![]() |
MMRV | measles, mumps, rubella, and varicella virus vaccine |
http://hl7.org/fhir/sid/cvx |
95 ![]() |
TST-OT tine test | tuberculin skin test; old tuberculin, multipuncture device |
http://hl7.org/fhir/sid/cvx |
96 ![]() |
TST-PPD intradermal | tuberculin skin test; purified protein derivative solution, intradermal |
http://hl7.org/fhir/sid/cvx |
97 ![]() |
TST-PPD tine test | tuberculin skin test; purified protein derivative, multipuncture device |
http://hl7.org/fhir/sid/cvx |
98 ![]() |
TST, unspecified formulation | tuberculin skin test; unspecified formulation |
http://hl7.org/fhir/sid/cvx |
99 ![]() |
RESERVED - do not use | RESERVED - do not use |
http://hl7.org/fhir/sid/cvx |
100 ![]() |
pneumococcal conjugate PCV 7 | pneumococcal conjugate vaccine, 7 valent |
http://hl7.org/fhir/sid/cvx |
101 ![]() |
typhoid, ViCPs | typhoid Vi capsular polysaccharide vaccine |
http://hl7.org/fhir/sid/cvx |
102 ![]() |
DTP-Hib-Hep B | DTP- Haemophilus influenzae type b conjugate and hepatitis b vaccine |
http://hl7.org/fhir/sid/cvx |
103 ![]() |
meningococcal C conjugate | meningococcal C conjugate vaccine |
http://hl7.org/fhir/sid/cvx |
104 ![]() |
Hep A-Hep B | hepatitis A and hepatitis B vaccine |
http://hl7.org/fhir/sid/cvx |
105 ![]() |
vaccinia (smallpox) diluted | vaccinia (smallpox) vaccine, diluted |
http://hl7.org/fhir/sid/cvx |
106 ![]() |
DTaP, 5 pertussis antigens | diphtheria, tetanus toxoids and acellular pertussis vaccine, 5 pertussis antigens |
http://hl7.org/fhir/sid/cvx |
107 ![]() |
DTaP, unspecified formulation | diphtheria, tetanus toxoids and acellular pertussis vaccine, unspecified formulation |
http://hl7.org/fhir/sid/cvx |
108 ![]() |
meningococcal ACWY, unspecified formulation | meningococcal ACWY vaccine, unspecified formulation |
http://hl7.org/fhir/sid/cvx |
109 ![]() |
pneumococcal, unspecified formulation | pneumococcal vaccine, unspecified formulation |
http://hl7.org/fhir/sid/cvx |
110 ![]() |
DTaP-Hep B-IPV | DTaP-hepatitis B and poliovirus vaccine |
http://hl7.org/fhir/sid/cvx |
111 ![]() |
Influenza, live, trivalent, intranasal, PF | Influenza, live, trivalent, intranasal, preservative free |
http://hl7.org/fhir/sid/cvx |
112 ![]() |
tetanus toxoid, unspecified formulation | tetanus toxoid, unspecified formulation |
http://hl7.org/fhir/sid/cvx |
113 ![]() |
Td (adult), 5 Lf tetanus toxoid, preservative free, adsorbed | tetanus and diphtheria toxoids, adsorbed, preservative free, for adult use (5 Lf of tetanus toxoid and 2 Lf of diphtheria toxoid) |
http://hl7.org/fhir/sid/cvx |
114 ![]() |
meningococcal MCV4P | meningococcal polysaccharide (groups A, C, Y and W-135) diphtheria toxoid conjugate vaccine (MCV4P) |
http://hl7.org/fhir/sid/cvx |
115 ![]() |
Tdap | tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine, adsorbed |
http://hl7.org/fhir/sid/cvx |
116 ![]() |
rotavirus, pentavalent | rotavirus, live, pentavalent vaccine |
http://hl7.org/fhir/sid/cvx |
117 ![]() |
VZIG (IND) | varicella zoster immune globulin (Investigational New Drug) |
http://hl7.org/fhir/sid/cvx |
118 ![]() |
HPV, bivalent | human papilloma virus vaccine, bivalent |
http://hl7.org/fhir/sid/cvx |
119 ![]() |
rotavirus, monovalent | rotavirus, live, monovalent vaccine |
http://hl7.org/fhir/sid/cvx |
120 ![]() |
DTaP-Hib-IPV | diphtheria, tetanus toxoids and acellular pertussis vaccine, Haemophilus influenzae type b conjugate, and poliovirus vaccine, inactivated (DTaP-Hib-IPV) |
http://hl7.org/fhir/sid/cvx |
121 ![]() |
zoster live | zoster vaccine, live |
http://hl7.org/fhir/sid/cvx |
122 ![]() |
rotavirus, unspecified formulation | rotavirus vaccine, unspecified formulation |
http://hl7.org/fhir/sid/cvx |
123 ![]() |
influenza, H5N1-1203 | influenza virus vaccine, H5N1, A/Vietnam/1203/2004 (national stockpile) |
http://hl7.org/fhir/sid/cvx |
125 ![]() |
Novel Influenza-H1N1-09, nasal | Novel Influenza-H1N1-09, live virus for nasal administration |
http://hl7.org/fhir/sid/cvx |
126 ![]() |
Novel influenza-H1N1-09, preservative-free | Novel influenza-H1N1-09, preservative-free, injectable |
http://hl7.org/fhir/sid/cvx |
127 ![]() |
Novel influenza-H1N1-09 | Novel influenza-H1N1-09, injectable |
http://hl7.org/fhir/sid/cvx |
128 ![]() |
Novel Influenza-H1N1-09, all formulations | Novel influenza-H1N1-09, all formulations |
http://hl7.org/fhir/sid/cvx |
129 ![]() |
Japanese Encephalitis, unspecified formulation | Japanese Encephalitis vaccine, unspecified formulation |
http://hl7.org/fhir/sid/cvx |
130 ![]() |
DTaP-IPV | Diphtheria, tetanus toxoids and acellular pertussis vaccine, and poliovirus vaccine, inactivated |
http://hl7.org/fhir/sid/cvx |
131 ![]() |
typhus, historical | Historical record of a typhus vaccination |
http://hl7.org/fhir/sid/cvx |
132 ![]() |
DTaP-IPV-HIB-HEP B, historical | Historical diphtheria and tetanus toxoids and acellular pertussis, poliovirus, Haemophilus b conjugate and hepatitis B (recombinant) vaccine. |
http://hl7.org/fhir/sid/cvx |
133 ![]() |
Pneumococcal conjugate PCV 13 | pneumococcal conjugate vaccine, 13 valent |
http://hl7.org/fhir/sid/cvx |
134 ![]() |
Japanese Encephalitis IM | Japanese Encephalitis vaccine for intramuscular administration |
http://hl7.org/fhir/sid/cvx |
135 ![]() |
Influenza, high-dose, trivalent, PF | Influenza, high-dose, split virus, trivalent, injectable, preservative free |
http://hl7.org/fhir/sid/cvx |
136 ![]() |
Meningococcal MCV4O | meningococcal oligosaccharide (groups A, C, Y and W-135) diphtheria toxoid conjugate vaccine (MCV4O) |
http://hl7.org/fhir/sid/cvx |
137 ![]() |
HPV, unspecified formulation | HPV, unspecified formulation |
http://hl7.org/fhir/sid/cvx |
138 ![]() |
Td (adult) | tetanus and diphtheria toxoids, not adsorbed, for adult use |
http://hl7.org/fhir/sid/cvx |
139 ![]() |
Td(adult) unspecified formulation | Td(adult) unspecified formulation |
http://hl7.org/fhir/sid/cvx |
140 ![]() |
Influenza, split virus, trivalent, PF | Influenza, split virus, trivalent, injectable, preservative free |
http://hl7.org/fhir/sid/cvx |
141 ![]() |
Influenza, split virus, trivalent, preservative | Influenza, split virus, trivalent, injectable, contains preservative |
http://hl7.org/fhir/sid/cvx |
142 ![]() |
tetanus toxoid, not adsorbed | tetanus toxoid, not adsorbed |
http://hl7.org/fhir/sid/cvx |
143 ![]() |
Adenovirus types 4 and 7 | Adenovirus, type 4 and type 7, live, oral |
http://hl7.org/fhir/sid/cvx |
144 ![]() |
influenza, seasonal, intradermal, preservative free | seasonal influenza, intradermal, preservative free |
http://hl7.org/fhir/sid/cvx |
145 ![]() |
RSV-MAb (new) | respiratory syncytial virus monoclonal antibody (motavizumab), intramuscular |
http://hl7.org/fhir/sid/cvx |
146 ![]() |
DTaP,IPV,Hib,HepB | Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Inactivated Poliovirus, Haemophilus b Conjugate (Meningococcal Protein Conjugate), and Hepatitis B (Recombinant) Vaccine. |
http://hl7.org/fhir/sid/cvx |
147 ![]() |
meningococcal MCV4, unspecified formulation | Meningococcal, MCV4, unspecified conjugate formulation(groups A, C, Y and W-135) |
http://hl7.org/fhir/sid/cvx |
148 ![]() |
Meningococcal C/Y-HIB PRP | Meningococcal Groups C and Y and Haemophilus b Tetanus Toxoid Conjugate Vaccine |
http://hl7.org/fhir/sid/cvx |
149 ![]() |
Influenza, live, quadrivalent, intranasal | Influenza, live, quadrivalent, intranasal |
http://hl7.org/fhir/sid/cvx |
150 ![]() |
Influenza, split virus, quadrivalent, PF | Influenza, split virus, quadrivalent, injectable, preservative free |
http://hl7.org/fhir/sid/cvx |
151 ![]() |
influenza nasal, unspecified formulation | influenza nasal, unspecified formulation |
http://hl7.org/fhir/sid/cvx |
152 ![]() |
Pneumococcal Conjugate, unspecified formulation | Pneumococcal Conjugate, unspecified formulation |
http://hl7.org/fhir/sid/cvx |
153 ![]() |
Influenza, MDCK, trivalent, PF | Influenza, Madin Darby Canine Kidney, subunit, trivalent, injectable, preservative free |
http://hl7.org/fhir/sid/cvx |
154 ![]() |
Hep A, IG | Hepatitis A immune globulin |
http://hl7.org/fhir/sid/cvx |
155 ![]() |
Influenza, recombinant, trivalent, PF | Influenza, recombinant, trivalent, injectable, preservative free |
http://hl7.org/fhir/sid/cvx |
156 ![]() |
Rho(D)-IG | Rho(D) Immune globulin- IV or IM |
http://hl7.org/fhir/sid/cvx |
157 ![]() |
Rho(D) -IG IM | Rho(D) Immune globulin - IM |
http://hl7.org/fhir/sid/cvx |
158 ![]() |
Influenza, split virus, quadrivalent, preservative | Influenza, split virus, quadrivalent, injectable, contains preservative |
http://hl7.org/fhir/sid/cvx |
159 ![]() |
Rho(D) - Unspecified formulation | Rho(D) Unspecified formulation |
http://hl7.org/fhir/sid/cvx |
160 ![]() |
Influenza A monovalent (H5N1), ADJUVANTED-2013 | Influenza A monovalent (H5N1), adjuvanted, National stockpile 2013 |
http://hl7.org/fhir/sid/cvx |
161 ![]() |
Influenza, injectable,quadrivalent, preservative free, pediatric | Influenza, injectable,quadrivalent, preservative free, pediatric |
http://hl7.org/fhir/sid/cvx |
162 ![]() |
meningococcal B, recombinant | meningococcal B vaccine, fully recombinant |
http://hl7.org/fhir/sid/cvx |
163 ![]() |
meningococcal B, OMV | meningococcal B vaccine, recombinant, OMV, adjuvanted |
http://hl7.org/fhir/sid/cvx |
164 ![]() |
meningococcal B, unspecified | meningococcal B, unspecified formulation |
http://hl7.org/fhir/sid/cvx |
165 ![]() |
HPV9 | Human Papillomavirus 9-valent vaccine |
http://hl7.org/fhir/sid/cvx |
166 ![]() |
influenza, intradermal, quadrivalent, preservative free | influenza, intradermal, quadrivalent, preservative free, injectable |
http://hl7.org/fhir/sid/cvx |
167 ![]() |
meningococcal, unknown serogroups | meningococcal vaccine of unknown formulation and unknown serogroups |
http://hl7.org/fhir/sid/cvx |
168 ![]() |
Influenza, adjuvanted, trivalent, PF | Influenza, adjuvanted, inactivated, trivalent, injectable, preservative free |
http://hl7.org/fhir/sid/cvx |
169 ![]() |
Hep A, live attenuated | Hep A, live attenuated-IM |
http://hl7.org/fhir/sid/cvx |
170 ![]() |
DTAP/IPV/HIB - non-US | non-US diphtheria, tetanus toxoids and acellular pertussis vaccine, Haemophilus influenzae type b conjugate, and poliovirus vaccine, inactivated (DTaP-Hib-IPV) |
http://hl7.org/fhir/sid/cvx |
171 ![]() |
Influenza, MDCK, quadrivalent, PF | Influenza, Madin Darby Canine Kidney, subunit, quadrivalent, injectable, preservative free |
http://hl7.org/fhir/sid/cvx |
172 ![]() |
cholera, WC-rBS | cholera, WC-rBS |
http://hl7.org/fhir/sid/cvx |
173 ![]() |
cholera, BivWC | cholera, BivWC |
http://hl7.org/fhir/sid/cvx |
174 ![]() |
cholera, live attenuated | cholera, live attenuated |
http://hl7.org/fhir/sid/cvx |
175 ![]() |
Rabies - IM Diploid cell culture | Human Rabies vaccine from human diploid cell culture |
http://hl7.org/fhir/sid/cvx |
176 ![]() |
Rabies - IM fibroblast culture | Human rabies vaccine from Chicken fibroblast culture |
http://hl7.org/fhir/sid/cvx |
177 ![]() |
PCV10 | pneumococcal conjugate vaccine, 10 valent |
http://hl7.org/fhir/sid/cvx |
178 ![]() |
OPV bivalent | Non-US bivalent oral polio vaccine (types 1 and 3) |
http://hl7.org/fhir/sid/cvx |
179 ![]() |
OPV ,monovalent, unspecified | Non-US monovalent oral polio vaccine, unspecified formulation |
http://hl7.org/fhir/sid/cvx |
180 ![]() |
tetanus immune globulin | tetanus immune globulin |
http://hl7.org/fhir/sid/cvx |
181 ![]() |
anthrax immune globulin | anthrax immune globulin |
http://hl7.org/fhir/sid/cvx |
182 ![]() |
OPV, Unspecified | Oral Polio Vaccine, Unspecified formulation |
http://hl7.org/fhir/sid/cvx |
183 ![]() |
Yellow fever vaccine live - alt | Yellow fever vaccine live - alternative formulation for vaccine shortage |
http://hl7.org/fhir/sid/cvx |
184 ![]() |
Yellow fever, unspecified | Yellow fever vaccine, unspecified formulation |
http://hl7.org/fhir/sid/cvx |
185 ![]() |
Influenza, recombinant, quadrivalent, PF | Influenza, recombinant, quadrivalent, injectable, preservative free |
http://hl7.org/fhir/sid/cvx |
186 ![]() |
Influenza, MDCK, quadrivalent, preservative | Influenza, Madin Darby Canine Kidney, subunit, quadrivalent, injectable, contains preservative |
http://hl7.org/fhir/sid/cvx |
187 ![]() |
zoster recombinant | zoster vaccine recombinant |
http://hl7.org/fhir/sid/cvx |
188 ![]() |
zoster, unspecified formulation | zoster vaccine, unspecified formulation |
http://hl7.org/fhir/sid/cvx |
189 ![]() |
HepB-CpG | Hepatitis B vaccine (recombinant), CpG adjuvanted |
http://hl7.org/fhir/sid/cvx |
190 ![]() |
Typhoid conjugate vaccine (TCV) | Typhoid conjugate vaccine (non-US) |
http://hl7.org/fhir/sid/cvx |
191 ![]() |
meningococcal A polysaccharide (non-US) | meningococcal A polysaccharide vaccine (non-US) |
http://hl7.org/fhir/sid/cvx |
192 ![]() |
meningococcal AC polysaccharide (non-US) | meningococcal AC polysaccharide vaccine (non-US) |
http://hl7.org/fhir/sid/cvx |
193 ![]() |
Hep A-Hep B, pediatric/adolescent | hepatitis A and hepatitis B vaccine, pediatric/adolescent (non-US) |
http://hl7.org/fhir/sid/cvx |
194 ![]() |
Influenza, Southern Hemisphere | influenza, Southern Hemisphere, unspecified formulation |
http://hl7.org/fhir/sid/cvx |
195 ![]() |
DT, IPV adsorbed | Diphtheria, Tetanus, Poliomyelitis adsorbed |
http://hl7.org/fhir/sid/cvx |
196 ![]() |
Td, adsorbed, preservative free, adult use, Lf unspecified | tetanus and diphtheria toxoids, adsorbed, preservative free, for adult use, Lf unspecified |
http://hl7.org/fhir/sid/cvx |
197 ![]() |
Influenza, high-dose, quadrivalent, PF | Influenza, high-dose, split virus, quadrivalent, injectable, preservative free |
http://hl7.org/fhir/sid/cvx |
198 ![]() |
DTP-hepB-Hib Pentavalent Non-US | Diphtheria, pertussis, tetanus, hepatitis B, Haemophilus Influenza Type b, (Pentavalent) |
http://hl7.org/fhir/sid/cvx |
200 ![]() |
influenza, Southern Hemisphere, pediatric, preservative free | influenza, seasonal, Southern Hemisphere, quadrivalent, pediatric 0.25mL dose, preservative free |
http://hl7.org/fhir/sid/cvx |
201 ![]() |
Influenza, Southern Hemisphere, quadrivalent, PF | Influenza, seasonal, Southern Hemisphere, quadrivalent, 0.5 mL dose, preservative free |
http://hl7.org/fhir/sid/cvx |
202 ![]() |
influenza, Southern Hemisphere, quadrivalent, with preservative | influenza, seasonal, Southern Hemisphere, quadrivalent, 0.5mL dose, with preservative |
http://hl7.org/fhir/sid/cvx |
203 ![]() |
meningococcal conjugate quadrivalent, MenACWY-TT (MCV4) | meningococcal polysaccharide (groups A, C, Y, W-135) tetanus toxoid conjugate vaccine 0.5mL dose, preservative free |
http://hl7.org/fhir/sid/cvx |
204 ![]() |
Ebola Zaire vaccine, live, recombinant, 1mL dose | Ebola Zaire vaccine, live, recombinant, 1mL dose |
http://hl7.org/fhir/sid/cvx |
205 ![]() |
Influenza, adjuvanted, quadrivalent, PF | Influenza, adjuvanted, inactivated, quadrivalent, injectable, preservative free |
http://hl7.org/fhir/sid/cvx |
206 ![]() |
Vaccinia, smallpox Mpox vaccine live, PF, SQ or ID injection | Vaccinia, smallpox monkeypox vaccine, live attenuated, preservative free, subcutaneous or intradermal injection |
http://hl7.org/fhir/sid/cvx |
207 ![]() |
COVID-19, mRNA, LNP-S, PF, 100 mcg/0.5mL dose or 50 mcg/0.25mL dose | SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 100 mcg/0.5mL dose or 50 mcg/0.25mL dose |
http://hl7.org/fhir/sid/cvx |
208 ![]() |
COVID-19, mRNA, LNP-S, PF, 30 mcg/0.3 mL dose | SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 30 mcg/0.3mL dose |
http://hl7.org/fhir/sid/cvx |
210 ![]() |
COVID-19 vaccine, vector-nr, rS-ChAdOx1, PF, 0.5 mL | SARS-COV-2 (COVID-19) vaccine, vector non-replicating, recombinant spike protein-ChAdOx1, preservative free, 0.5 mL |
http://hl7.org/fhir/sid/cvx |
211 ![]() |
COVID-19, subunit, rS-nanoparticle+Matrix-M1 Adjuvant, PF, 0.5 mL | SARS-COV-2 (COVID-19) vaccine, subunit, recombinant spike protein-nanoparticle+Matrix-M1 Adjuvant, preservative free, 0.5mL dose |
http://hl7.org/fhir/sid/cvx |
212 ![]() |
COVID-19 vaccine, vector-nr, rS-Ad26, PF, 0.5 mL | SARS-COV-2 (COVID-19) vaccine, vector non-replicating, recombinant spike protein-Ad26, preservative free, 0.5 mL |
http://hl7.org/fhir/sid/cvx |
213 ![]() |
SARS-COV-2 (COVID-19) vaccine, UNSPECIFIED | SARS-COV-2 (COVID-19) vaccine, UNSPECIFIED |
http://hl7.org/fhir/sid/cvx |
214 ![]() |
Ebola, unspecified | Ebola, unspecified |
http://hl7.org/fhir/sid/cvx |
215 ![]() |
Pneumococcal conjugate PCV15, polysaccharide CRM197 conjugate, adjuvant, PF | Pneumococcal conjugate vaccine 15-valent (PCV15), polysaccharide CRM197 conjugate, adjuvant, preservative free |
http://hl7.org/fhir/sid/cvx |
216 ![]() |
Pneumococcal conjugate PCV20, polysaccharide CRM197 conjugate, adjuvant, PF | Pneumococcal conjugate vaccine 20-valent (PCV20), polysaccharide CRM197 conjugate, adjuvant, preservative free |
http://hl7.org/fhir/sid/cvx |
217 ![]() |
COVID-19, mRNA, LNP-S, PF, 30 mcg/0.3 mL dose, tris-sucrose | SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 30 mcg/0.3mL dose, tris-sucrose formulation |
http://hl7.org/fhir/sid/cvx |
218 ![]() |
COVID-19, mRNA, LNP-S, PF, 10 mcg/0.2 mL dose, tris-sucrose | SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 10 mcg/0.2mL dose, tris-sucrose formulation |
http://hl7.org/fhir/sid/cvx |
219 ![]() |
COVID-19, mRNA, LNP-S, PF, 3 mcg/0.2 mL dose, tris-sucrose | SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 3 mcg/0.2mL dose, tris-sucrose formulation |
http://hl7.org/fhir/sid/cvx |
220 ![]() |
HepB recombinant, 3-antigen, Al(OH)3 | Hepatitis B vaccine (recombinant), 3-antigen, Al(OH)3 adjuvanted |
http://hl7.org/fhir/sid/cvx |
221 ![]() |
COVID-19, mRNA, LNP-S, PF, 50 mcg/0.5 mL dose | SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 50 mcg/0.5 mL dose |
http://hl7.org/fhir/sid/cvx |
222 ![]() |
Tick-borne encephalitis, unspecified | Tick-borne encephalitis vaccine, unspecified |
http://hl7.org/fhir/sid/cvx |
223 ![]() |
Tick-borne encephalitis, inactivated, PF, 0.25mL | Tick-borne encephalitis vaccine, inactivated, preservative free, 0.25mL dose |
http://hl7.org/fhir/sid/cvx |
224 ![]() |
Tick-borne encephalitis, inactivated, PF, 0.5mL | Tick-borne encephalitis vaccine, inactivated, preservative free, 0.5mL dose |
http://hl7.org/fhir/sid/cvx |
225 ![]() |
COVID-19, D614, recomb, preS dTM, AS03 adjuvant add, PF, 5mcg/0.5mL | SARS-COV-2 (COVID-19) vaccine, D614, prefusion spike recombinant protein subunit (CoV2 preS dTM), AS03 adjuvant added, preservative free, 5mcg/0.5mL dose |
http://hl7.org/fhir/sid/cvx |
226 ![]() |
COVID-19, D614, recomb, preS dTM, AS03 adjuvant add, PF, 10mcg/0.5mL | SARS-COV-2 (COVID-19) vaccine, D614, prefusion spike recombinant protein subunit (CoV2 preS dTM), AS03 adjuvant added, preservative free, 10mcg/0.5mL dose |
http://hl7.org/fhir/sid/cvx |
227 ![]() |
COVID-19, mRNA, LNP-S, PF, pediatric 50 mcg/0.5 mL dose | SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, pediatric 50 mcg/0.5 mL dose |
http://hl7.org/fhir/sid/cvx |
228 ![]() |
COVID-19, mRNA, LNP-S, PF, pediatric 25 mcg/0.25 mL dose | SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, pediatric 25 mcg/0.25 mL dose |
http://hl7.org/fhir/sid/cvx |
229 ![]() |
COVID-19, mRNA, LNP-S, bivalent, PF, 50 mcg/0.5 mL or 25mcg/0.25 mL dose | SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, bivalent, preservative free, 50 mcg/0.5 mL or 25 mcg/0.25 mL dose |
http://hl7.org/fhir/sid/cvx |
230 ![]() |
COVID-19, mRNA, LNP-S, bivalent, PF, 10 mcg/0.2 mL | SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, bivalent, preservative free, 10 mcg/0.2 mL dose |
http://hl7.org/fhir/sid/cvx |
231 ![]() |
influenza, Southern Hemisphere, high-dose, quadrivalent | influenza, seasonal, Southern Hemisphere, high-dose, quadrivalent, 0.7mL dose, preservative free |
http://hl7.org/fhir/sid/cvx |
300 ![]() |
COVID-19, mRNA, LNP-S, bivalent, PF, 30 mcg/0.3 mL dose | SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, bivalent, preservative free, 30 mcg/0.3 mL dose, tris-sucrose formulation |
http://hl7.org/fhir/sid/cvx |
301 ![]() |
COVID-19, mRNA, LNP-S, bivalent, PF, 10 mcg/0.2 mL dose | SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, bivalent, preservative free, 10 mcg/0.2 mL dose, tris-sucrose formulation |
http://hl7.org/fhir/sid/cvx |
302 ![]() |
COVID-19, mRNA, LNP-S, bivalent, PF, 3 mcg/0.2 mL dose | SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, bivalent, preservative free, 3 mcg/0.2 mL dose, tris-sucrose formulation |
http://hl7.org/fhir/sid/cvx |
303 ![]() |
RSV, recombinant, protein subunit RSVpreF, adjuvant reconstituted, 0.5 mL, PF | Respiratory syncytial virus (RSV), vaccine, recombinant, protein subunit RSV prefusion F, adjuvant reconstituted, 0.5 mL, preservative free |
http://hl7.org/fhir/sid/cvx |
304 ![]() |
Respiratory syncytial virus (RSV), unspecified | Respiratory syncytial virus (RSV), unspecified |
http://hl7.org/fhir/sid/cvx |
305 ![]() |
RSV, bivalent, protein subunit RSVpreF, diluent reconstituted, 0.5 mL, PF | Respiratory syncytial virus (RSV), vaccine, bivalent, protein subunit RSV prefusion F, diluent reconstituted, 0.5 mL, preservative free |
http://hl7.org/fhir/sid/cvx |
306 ![]() |
RSV, mAb, nirsevimab-alip, 0.5 mL, neonate to 24 months | Respiratory syncytial virus (RSV) monoclonal antibody, IgG1κ , (nirsevimab-alip), 0.5 mL, neonates and children to 24 months |
http://hl7.org/fhir/sid/cvx |
307 ![]() |
RSV, mAb, nirsevimab-alip, 1 mL, neonate to 24 months | Respiratory syncytial virus (RSV) monoclonal antibody, IgG1κ , (nirsevimab-alip), 1 mL, neonates and children to 24 months |
http://hl7.org/fhir/sid/cvx |
308 ![]() |
COVID-19, mRNA, LNP-S, PF, tris-sucrose, 3 mcg/0.3 mL | SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, tris-sucrose, 3 mcg/0.3 mL dose |
http://hl7.org/fhir/sid/cvx |
309 ![]() |
COVID-19, mRNA, LNP-S, PF, tris-sucrose, 30 mcg/0.3 mL | SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, tris-sucrose, 30 mcg/0.3 mL dose |
http://hl7.org/fhir/sid/cvx |
310 ![]() |
COVID-19, mRNA, LNP-S, PF, tris-sucrose, 10 mcg/0.3 mL | SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, tris-sucrose, 10 mcg/0.3 mL dose |
http://hl7.org/fhir/sid/cvx |
311 ![]() |
COVID-19, mRNA, LNP-S, PF, 25 mcg/0.25 mL | SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 25 mcg/0.25 mL dose |
http://hl7.org/fhir/sid/cvx |
312 ![]() |
COVID-19, mRNA, LNP-S, PF, 50 mcg/0.5 mL | SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 50 mcg/0.5 mL dose |
http://hl7.org/fhir/sid/cvx |
313 ![]() |
COVID-19, subunit, rS-nanoparticle, adjuvanted, PF, 5 mcg/0.5 mL | SARS-COV-2 (COVID-19) vaccine, subunit, recombinant spike protein-nanoparticle+Matrix-M1 Adjuvant, preservative free, 5 mcg/0.5 mL dose |
http://hl7.org/fhir/sid/cvx |
314 ![]() |
Respiratory syncytial virus (RSV) vaccine, unspecified | Respiratory syncytial virus (RSV) vaccine, unspecified |
http://hl7.org/fhir/sid/cvx |
315 ![]() |
Respiratory syncytial virus (RSV) MAB, unspecified | Respiratory syncytial virus (RSV) monoclonal antibody (MAB), unspecified |
http://hl7.org/fhir/sid/cvx |
316 ![]() |
Meningococcal polysaccharide (MenACWY-TT conjugate), (MenB), PF | Meningococcal polysaccharide (groups A, C, Y, W) tetanus toxoid conjugate, meningococcal B recombinant vaccine, 0.5mL, preservative free |
http://hl7.org/fhir/sid/cvx |
317 ![]() |
Chikungunya live attenuated vaccine, 0.5 mL, PF | Chikungunya, live attenuated vaccine, 0.5 mL, preservative free |
http://hl7.org/fhir/sid/cvx |
318 ![]() |
Anthrax, post-exposure prophylaxis | Anthrax vaccine, adsorbed, adjuvanted, post-exposure prophylaxis |
http://hl7.org/fhir/sid/cvx |
319 ![]() |
Anthrax vaccine, unspecified | Anthrax vaccine, unspecified |
http://hl7.org/fhir/sid/cvx |
320 ![]() |
Influenza, MDCK, trivalent, preservative | Influenza, Madin Darby Canine Kidney, subunit, trivalent, injectable, contains preservative |
http://hl7.org/fhir/sid/cvx |
321 ![]() |
Influenza-avian, H5N8, monovalent, PF | Influenza-avian, H5N8, viral-vector, monovalent, injectable, preservative free |
http://hl7.org/fhir/sid/cvx |
322 ![]() |
Influenza-avian, H5N8, monovalent, preservative | Influenza-avian, H5N8, viral-vector, monovalent, injectable, contains preservative |
http://hl7.org/fhir/sid/cvx |
323 ![]() |
Influenza-avian, H5, unspecified formulation | Influenza-avian, H5, unspecified formulation |
http://hl7.org/fhir/sid/cvx |
324 ![]() |
Poliovirus, inactivated, fractional-dose (fIPV) | Poliovirus, inactivated, fractional-dose (fIPV) |
http://hl7.org/fhir/sid/cvx |
325 ![]() |
Vaccinia (smallpox, mpox), unspecified | Vaccinia (smallpox, mpox), unspecified |
http://hl7.org/fhir/sid/cvx |
326 ![]() |
RSV, mRNA, injectable, PF | Respiratory syncytial virus (RSV), mRNA, injectable, preservative free |
http://hl7.org/fhir/sid/cvx |
327 ![]() |
Pneumococcal conjugate PCV21, polysaccharide CRM197 conjugate, PF | Pneumococcal conjugate vaccine, 21 valent (PCV21), polysaccharide CRM197 conjugate, preservative free |
http://hl7.org/fhir/sid/cvx |
328 ![]() |
Meningococcal oligosaccharide (MenACWY), (MenB), PF | Meningococcal oligosaccharide conjugated (groups A, C, W, Y) and group B, 0.5 mL, preservative free |
http://hl7.org/fhir/sid/cvx |
329 ![]() |
Chikungunya, VLP, recombinant, 0.8 mL, PF | Chikungunya, virus-like particle (VLP), recombinant vaccine, 0.8 mL, preservative free |
http://hl7.org/fhir/sid/cvx |
330 ![]() |
Dengue fever, unspecified | Dengue fever, unspecified formulation |
http://hl7.org/fhir/sid/cvx |
331 ![]() |
Influenza, Southern Hemisphere, trivalent, PF | Influenza, seasonal, Southern Hemisphere, trivalent, 0.5 mL dose, preservative free |
http://hl7.org/fhir/sid/cvx |
332 ![]() |
RSV, mAb, clesrovimab-cfor, 0.7 mL, neonate and infant, PF | Respiratory syncytial virus (RSV), monoclonal antibody, IgG1κ , (clesrovimab-cfor), 0.7 mL, neonate and infant, preservative free |
http://hl7.org/fhir/sid/cvx |
333 ![]() |
Influenza, live, trivalent, intranasal, self/caregiver admin, PF | Influenza, live, trivalent, intranasal, self or caregiver administered, preservative free |
http://hl7.org/fhir/sid/cvx |
500 ![]() |
COVID-19 Non-US Vaccine, Product Unknown | SARS-COV-2 COVID-19 Non-US Vaccine, Specific Product Unknown |
http://hl7.org/fhir/sid/cvx |
501 ![]() |
COVID-19 IV Non-US Vaccine (QAZCOVID-IN) | SARS-COV-2 COVID-19 Inactivated Virus Non-US Vaccine Product (QAZCOVID-IN) |
http://hl7.org/fhir/sid/cvx |
502 ![]() |
COVID-19 IV Non-US Vaccine (COVAXIN) | SARS-COV-2 COVID-19 Inactivated Virus Non-US Vaccine Product (COVAXIN) |
http://hl7.org/fhir/sid/cvx |
503 ![]() |
COVID-19 LAV Non-US Vaccine (COVIVAC) | SARS-COV-2 COVID-19 Live Attenuated Virus Non-US Vaccine Product (COVIVAC) |
http://hl7.org/fhir/sid/cvx |
504 ![]() |
COVID-19 VVnr Non-US Vaccine (Sputnik Light) | SARS-COV-2 COVID-19 Viral Vector Non-replicating Non-US Vaccine Product (Sputnik Light) |
http://hl7.org/fhir/sid/cvx |
505 ![]() |
COVID-19 VVnr Non-US Vaccine (Sputnik V) | SARS-COV-2 COVID-19 Viral Vector Non-replicating Non-US Vaccine Product (Sputnik V) |
http://hl7.org/fhir/sid/cvx |
506 ![]() |
COVID-19 VVnr Non-US Vaccine (CanSino Biological Inc./Beijing Institute of Biotechnology | SARS-COV-2 COVID-19 Viral Vector Non-replicating Non-US Vaccine Product (CONVIDECIA), CanSino Biological Inc./Beijing Institute of Biotechnology |
http://hl7.org/fhir/sid/cvx |
507 ![]() |
COVID-19 PS Non-US Vaccine (Anhui Zhifei Longcom Biopharm + Inst of Micro, Chinese Acad of Sciences) | SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (Anhui Zhifei Longcom Biopharmaceutical + Institute of Microbiology, Chinese Academy of Sciences) |
http://hl7.org/fhir/sid/cvx |
508 ![]() |
COVID-19 PS Non-US Vaccine (Jiangsu Province Centers for Disease Control and Prevention) | SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (Jiangsu Province Centers for Disease Control and Prevention) |
http://hl7.org/fhir/sid/cvx |
509 ![]() |
COVID-19 PS Non-US Vaccine (EpiVacCorona) | SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (EpiVacCorona) |
http://hl7.org/fhir/sid/cvx |
510 ![]() |
COVID-19 IV Non-US Vaccine (BIBP, Sinopharm) | SARS-COV-2 COVID-19 Inactivated Virus Non-US Vaccine Product (BIBP, Sinopharm) |
http://hl7.org/fhir/sid/cvx |
511 ![]() |
COVID-19 IV Non-US Vaccine (CoronaVac, Sinovac) | SARS-COV-2 COVID-19 Inactivated Virus Non-US Vaccine Product (CoronaVac, Sinovac) |
http://hl7.org/fhir/sid/cvx |
512 ![]() |
SARS-COV-2 COVID-19 VLP Non-US Vaccine (Medicago, Covifenz) | SARS-COV-2 COVID-19 Virus Like Particle (VLP) Non-US Vaccine Product (Medicago, Covifenz) |
http://hl7.org/fhir/sid/cvx |
513 ![]() |
SARS-COV-2 COVID-19 PS Non-US Vaccine (Anhui Zhifei Longcom, Zifivax) | SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (Anhui Zhifei Longcom, Zifivax) |
http://hl7.org/fhir/sid/cvx |
514 ![]() |
SARS-COV-2 COVID-19 DNA Non-US Vaccine (Zydus Cadila, ZyCoV-D) | SARS-COV-2 COVID-19 DNA Non-US Vaccine Product (Zydus Cadila, ZyCoV-D) |
http://hl7.org/fhir/sid/cvx |
515 ![]() |
SARS-COV-2 COVID-19 PS Non-US Vaccine (Medigen, MVC-COV1901) | SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (Medigen, MVC-COV1901) |
http://hl7.org/fhir/sid/cvx |
516 ![]() |
COV-2 COVID-19 Inactivated Non-US Vaccine Product (Minhai Biotechnology Co, KCONVAC) | SARS-COV-2 COVID-19 Inactivated Non-US Vaccine Product (Minhai Biotechnology Co, KCONVAC) |
http://hl7.org/fhir/sid/cvx |
517 ![]() |
SARS-COV-2 COVID-19 PS Non-US Vaccine (Biological E Limited, Corbevax) | SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (Biological E Limited, Corbevax) |
http://hl7.org/fhir/sid/cvx |
518 ![]() |
COVID-19 Inactivated, Non-US Vaccine (VLA2001, Valneva) | SARS-COV-2 COVID-19 Inactivated, Non-US Vaccine (VLA2001, Valneva) |
http://hl7.org/fhir/sid/cvx |
519 ![]() |
COVID-19 mRNA, bivalent, original/Omicron BA.1, Non-US Vaccine (Spikevax Bivalent), Moderna | SARS-COV-2 COVID-19 mRNA, bivalent, original/Omicron BA.1, Non-US Vaccine (Spikevax Bivalent), Moderna |
http://hl7.org/fhir/sid/cvx |
520 ![]() |
COVID-19 mRNA, bivalent, original/Omicron BA.1, Non-US Vaccine Product, Pfizer-BioNTech | SARS-COV-2 COVID-19 mRNA, bivalent, original/Omicron BA.1, Non-US Vaccine Product (Comirnaty Bivalent), Pfizer-BioNTech |
http://hl7.org/fhir/sid/cvx |
521 ![]() |
COVID-19 SP, protein-based, adjuvanted (VidPrevtyn Beta), Sanofi-GSK | SARS-COV-2 (COVID-19) vaccine SP, protein-based, adjuvanted, B.1.351 strain (VidPrevtyn Beta), Sanofi-GSK |
http://hl7.org/fhir/sid/cvx |
801 ![]() |
AS03 Adjuvant | AS03 Adjuvant |
http://hl7.org/fhir/sid/cvx |
998 ![]() |
no vaccine administered | no vaccine administered |
http://hl7.org/fhir/sid/cvx |
999 ![]() |
unknown | unknown vaccine or immune globulin |
urn:oid:1.2.36.1.2001.1005.17 |
AGRPAL | Agrippal | |
urn:oid:1.2.36.1.2001.1005.17 |
AVAXM | Avaxim | |
urn:oid:1.2.36.1.2001.1005.17 |
BCG | BCG | |
urn:oid:1.2.36.1.2001.1005.17 |
CDT | CDT | |
urn:oid:1.2.36.1.2001.1005.17 |
CMX | COMVAX | |
urn:oid:1.2.36.1.2001.1005.17 |
DTP | Triple Antigen | |
urn:oid:1.2.36.1.2001.1005.17 |
DTPA | DTPa | |
urn:oid:1.2.36.1.2001.1005.17 |
ENGP | Engerix B | |
urn:oid:1.2.36.1.2001.1005.17 |
FLRIX | Fluarix | |
urn:oid:1.2.36.1.2001.1005.17 |
FLUVAX | Fluvax | |
urn:oid:1.2.36.1.2001.1005.17 |
FLVRN | Fluvirin | |
urn:oid:1.2.36.1.2001.1005.17 |
FVXJNR | Fluvax Junior | |
urn:oid:1.2.36.1.2001.1005.17 |
GNDIP | Diphtheria | |
urn:oid:1.2.36.1.2001.1005.17 |
GNFLU | Influenza | |
urn:oid:1.2.36.1.2001.1005.17 |
GNHEP | Hepatitis B | |
urn:oid:1.2.36.1.2001.1005.17 |
GNHIB | HIB | |
urn:oid:1.2.36.1.2001.1005.17 |
GNHPA | Hepatitis A | |
urn:oid:1.2.36.1.2001.1005.17 |
GNJEN | Japanese Encephalitis | |
urn:oid:1.2.36.1.2001.1005.17 |
GNMEA | Measles | |
urn:oid:1.2.36.1.2001.1005.17 |
GNMEN | Meningococcal C | |
urn:oid:1.2.36.1.2001.1005.17 |
GNMUM | Mumps | |
urn:oid:1.2.36.1.2001.1005.17 |
GNPNE | Pneumococcal | |
urn:oid:1.2.36.1.2001.1005.17 |
GNPOL | Polio | |
urn:oid:1.2.36.1.2001.1005.17 |
GNROX | Rotavirus | |
urn:oid:1.2.36.1.2001.1005.17 |
GNRUB | Rubella | |
urn:oid:1.2.36.1.2001.1005.17 |
GNTET | Tetanus | |
urn:oid:1.2.36.1.2001.1005.17 |
GNVAR | Varicella | |
urn:oid:1.2.36.1.2001.1005.17 |
HATWNJ | Twinrix Junior | |
urn:oid:1.2.36.1.2001.1005.17 |
HAVAQ | Vaqta Paed/Adol | |
urn:oid:1.2.36.1.2001.1005.17 |
HAVJ | Havrix Junior | |
urn:oid:1.2.36.1.2001.1005.17 |
HBOC | HibTITER | |
urn:oid:1.2.36.1.2001.1005.17 |
HBV | HBV | |
urn:oid:1.2.36.1.2001.1005.17 |
HBVP | HBVAX II | |
urn:oid:1.2.36.1.2001.1005.17 |
HBX | Hiberix | |
urn:oid:1.2.36.1.2001.1005.17 |
IFHX | Infanrix Hexa | |
urn:oid:1.2.36.1.2001.1005.17 |
IFIP | Infanrix-IPV | |
urn:oid:1.2.36.1.2001.1005.17 |
IFPA | Infanrix Penta | |
urn:oid:1.2.36.1.2001.1005.17 |
IFX | Infanrix | |
urn:oid:1.2.36.1.2001.1005.17 |
IFXB | InfanrixHepB | |
urn:oid:1.2.36.1.2001.1005.17 |
INFLUV | Influvac | |
urn:oid:1.2.36.1.2001.1005.17 |
IPV | IPOL | |
urn:oid:1.2.36.1.2001.1005.17 |
JEVAX | JE-VAX | |
urn:oid:1.2.36.1.2001.1005.17 |
MENJUG | Menjugate | |
urn:oid:1.2.36.1.2001.1005.17 |
MENTEC | Meningitec | |
urn:oid:1.2.36.1.2001.1005.17 |
MENUME | Menomune | |
urn:oid:1.2.36.1.2001.1005.17 |
MENVAX | Mencevax ACWY | |
urn:oid:1.2.36.1.2001.1005.17 |
MMR | MMR | |
urn:oid:1.2.36.1.2001.1005.17 |
MMRCSL | MMR II | |
urn:oid:1.2.36.1.2001.1005.17 |
MMRSKB | Priorix | |
urn:oid:1.2.36.1.2001.1005.17 |
MNTRX | Menitorix | |
urn:oid:1.2.36.1.2001.1005.17 |
NEISVC | NeisVac-C | |
urn:oid:1.2.36.1.2001.1005.17 |
OPV | Polio | |
urn:oid:1.2.36.1.2001.1005.17 |
P | Pertussis | |
urn:oid:1.2.36.1.2001.1005.17 |
PANVAX | Panvax | |
urn:oid:1.2.36.1.2001.1005.17 |
PDCL | Pediacel | |
urn:oid:1.2.36.1.2001.1005.17 |
PLCL | Poliacel | |
urn:oid:1.2.36.1.2001.1005.17 |
PNEUMO | Pneumovax | |
urn:oid:1.2.36.1.2001.1005.17 |
PRPD | ProHIBit | |
urn:oid:1.2.36.1.2001.1005.17 |
PROQAD | ProQuad | |
urn:oid:1.2.36.1.2001.1005.17 |
PRPOMP | PedvaxHIB | |
urn:oid:1.2.36.1.2001.1005.17 |
PRPT | ActHIB | |
urn:oid:1.2.36.1.2001.1005.17 |
PRVNR | Prevenar 7 | |
urn:oid:1.2.36.1.2001.1005.17 |
PRVTH | Prevenar 13 | |
urn:oid:1.2.36.1.2001.1005.17 |
PRXTEX | Priorix-Tetra | |
urn:oid:1.2.36.1.2001.1005.17 |
QDCL | Quadracel | |
urn:oid:1.2.36.1.2001.1005.17 |
ROTRIX | Rotarix | |
urn:oid:1.2.36.1.2001.1005.17 |
ROTTEQ | Rotateq | |
urn:oid:1.2.36.1.2001.1005.17 |
SYNFLX | Synflorix | |
urn:oid:1.2.36.1.2001.1005.17 |
TCL | Tripacel | |
urn:oid:1.2.36.1.2001.1005.17 |
VAXGRP | Vaxigrip | |
urn:oid:1.2.36.1.2001.1005.17 |
VGRJNR | Vaxigrip Junior | |
urn:oid:1.2.36.1.2001.1005.17 |
VLRIX | Varilrix | |
urn:oid:1.2.36.1.2001.1005.17 |
VRVAX | Varivax |
See the full registry of value sets defined as part of FHIR.
Explanation of the columns that may appear on this page:
| Lvl | A few code lists that FHIR defines are hierarchical - each code is assigned a level. For value sets, levels are mostly used to organize codes for user convenience, but may follow code system hierarchy - see Code System for further information |
| Source | The source of the definition of the code (when the value set draws in codes defined elsewhere) |
| Code | The code (used as the code in the resource instance). If the code is in italics, this indicates that the code is not selectable ('Abstract') |
| Display | The display (used in the display element of a Coding). If there is no display, implementers should not simply display the code, but map the concept into their application |
| Definition | An explanation of the meaning of the concept |
| Comments | Additional notes about how to use the code |